CD68 and atherosclerosis: ApoE−/−FBXW2fl/flLysmCre+/− mice exhibited smaller lesions (Figure 3B) with fewer CD68+ plaque areas (Figure 3C), suggesting that FBXW2 deletion in macrophages may alleviate progression of atherosclerosis in mice.